Agios Pharma' PYRUKYND approved in the European Union for adults with Thalassemia
[출처/시간] Briefing.com - 9:16 AM ET, 05/22/2026 PYRUKYND is the only medicine approved in the EU for adults with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia.Mitapivat is now approved for thalassemia in the U.S., Saudi Arabia, United Arab Emirates, and EU.Avanzanite Bioscience B.V., a specialty pharmaceutical company, will continue to distribute and commercialize PYRUKYND in Europe.
[출처/시간] Briefing.com - 9:16 AM ET, 05/22/2026
PYRUKYND is the only medicine approved in the EU for adults with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia.Mitapivat is now approved for thalassemia in the U.S., Saudi Arabia, United Arab Emirates, and EU.Avanzanite Bioscience B.V., a specialty pharmaceutical company, will continue to distribute and commercialize PYRUKYND in Europe.
당신의 반응은 무엇인가요?
좋아요
0
싫어요
0
사랑
0
재미있는
0
화난
0
슬프다
0
와우
0
